ALDH1 inhibitors, such as diethylaminobenzaldehyde, combined with chemotherapy (e.g., dacarbazine), significantly reduce tumor growth and the number of residual tumorigenic cells in melanoma xenografts [134]. The gene discussed is ALDH1A1; the disease is neoplasm.